Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
274.66
-8.42 (-2.97%)
At close: Aug 1, 2025, 4:00 PM
275.00
+0.34 (0.12%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Aspen Technology Employees
Elevance Health had 104,200 employees as of December 31, 2024. The number of employees decreased by 700 or -0.67% compared to the previous year.
Employees
104,200
Change (1Y)
-700
Growth (1Y)
-0.67%
Revenue / Employee
$1,816,257
Profits / Employee
$51,440
Market Cap
61.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 104,200 | -700 | -0.67% |
Dec 31, 2023 | 104,900 | 2,600 | 2.54% |
Dec 31, 2022 | 102,300 | 4,100 | 4.18% |
Dec 31, 2021 | 98,200 | 14,800 | 17.75% |
Dec 31, 2020 | 83,400 | 12,800 | 18.13% |
Dec 31, 2019 | 70,600 | 6,700 | 10.49% |
Dec 31, 2018 | 63,900 | 7,900 | 14.11% |
Dec 31, 2017 | 56,000 | 3,000 | 5.66% |
Dec 31, 2016 | 53,000 | 0 | - |
Dec 31, 2015 | 53,000 | 1,500 | 2.91% |
Dec 31, 2014 | 51,500 | 3,300 | 6.85% |
Dec 31, 2013 | 48,200 | 4,700 | 10.80% |
Dec 31, 2012 | 43,500 | 5,800 | 15.38% |
Dec 31, 2011 | 37,700 | 200 | 0.53% |
Dec 31, 2010 | 37,500 | -3,000 | -7.41% |
Dec 31, 2009 | 40,500 | -2,400 | -5.59% |
Dec 31, 2008 | 42,900 | 1,200 | 2.88% |
Dec 31, 2007 | 41,700 | -300 | -0.71% |
Dec 31, 2006 | 42,000 | 0 | - |
Dec 31, 2005 | 42,000 | 4,000 | 10.53% |
Dec 31, 2004 | 38,000 | 17,870 | 88.77% |
Dec 31, 2003 | 20,130 | 630 | 3.23% |
Dec 31, 2002 | 19,500 | 4,700 | 31.76% |
Dec 31, 2001 | 14,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ELV News
- 4 days ago - Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - Business Wire
- 8 days ago - Centene, Cigna, Others Drop As Molina's Results Rattle Sector - Benzinga
- 8 days ago - Elevance Health: CEO Buys As CareBridge Drives Strong Growth - Seeking Alpha
- 10 days ago - Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults - Business Wire
- 15 days ago - S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles - Investopedia
- 15 days ago - Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More - Investopedia
- 15 days ago - Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers. - Barrons